[Brain metastases from breast cancer: usefulness and limits of prognostic scores].

@article{Scodan2011BrainMF,
  title={[Brain metastases from breast cancer: usefulness and limits of prognostic scores].},
  author={Romuald Le Scodan and Christophe C Massard and Ludivine Jouanneau and Maya Gutierrez and Emmanuelle Mouret-Fourme},
  journal={Bulletin du cancer},
  year={2011},
  volume={98 4},
  pages={377-84}
}
Approximately 10 to 30% of patients with metastatic breast cancer will develop brain metastases (BM) during the disease course. Whole-brain radiation therapy (WBRT) is considered the standard treatment for most patients, particularly those with extensive intracranial disease, providing symptom relief and increasing median and overall survival. Despite WBRT… CONTINUE READING